BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Raphe Nuclei

Below is an extended Raphe Nuclei patents listing. Click here to return to the Raphe Nuclei main in depth entry.

Patents :

US Patent No.Title
6808530 Medical device for treatment of a gap or defect in the central nerve system
7034118 Corticotropin-releasing factor.sub.2 receptors
7045678 Transgenic mouse for screening therapeutic agents for brain tumors
7049429 Mutations of the 5' region of the human 5-HT1A gene
7056921 Substituted chroman derivatives
7060450 Screening assays for agonists and antagonists of the hedgehog signaling pathway
7081470 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
7098233 5-halo-tryptamine derivatives used as ligands on the 5-HT.sub.6 and/or 5-HT.sub.7 serotonin receptors
7101540 Targeted retrograde gene delivery to motor neurons
7112319 Identification, diagnosis, and treatment of neuropathologies, neurotoxicities, tumors, and brain and spinal cord injuries using microelectrodes with microvoltammetry
7112668 Polypeptides and nucleic acids encoded thereby
7034114 "Signalin" family of TGF.beta. signal transduction proteins, and uses related thereto
6998118 Targeted retrograde gene delivery for neuronal protection
6987005 DNA encoding SNORF33 receptor
6818391 Glutamate transporters
6828351 Methods and compositions for regulating memory consolidation
6838274 Urocortin proteins and uses thereof
6846823 Method of treating lower urinary tract disorders
6849727 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
6921538 Therapeutic treatments for neuropsychiatric disorders
6922590 Systems and methods for treatment of diabetes by electrical brain stimulation and/or drug infusion
6936607 2,4,6-Triaminopyrimidines for the treatment of depression and/or anxiety
6950707 Systems and methods for treatment of obesity and eating disorders by electrical brain stimulation and/or drug infusion
6984518 DNA construct comprising an FGF1B promoter region operably linked to an SV40 large T antigen encoding sequence
7115099 Method and apparatus for diagnosis of a mood disorder or predisposition therefor
7115394 Hedgehog interacting proteins and uses related thereto
7264968 Method of inducing and maintaining neuronal cells
7270965 Assays to screen for compounds that bind the dorsal root receptor
7273618 Method for administering agents to the central nervous system
7276339 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
7291737 Cocaine receptor binding ligands
7371535 Processes for determining compounds that interact with snorf33 receptor
7384943 Substituted chroman derivatives
7393864 Use of ClC3 chloride channel blockers to modulate vascular tone
7405053 Materials and methods relating to G-protein coupled receptor oligomers
7416848 DNA encoding SNORF25 receptor
7252945 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
7252934 Synergistic activation of regulatory elements by Rel proteins and a steroid receptor
7244769 Methods for treating an impairment in memory consolidation
7115606 Method of treating lower urinary tract disorders
7115653 Small organic molecule regulators of cell proliferation
7141546 CRFR2 selective ligands
7144732 Vertebrate embryonic pattern-inducing proteins and uses related thereto
7166635 3-imino-2-indolones for the treatment of depression and/or anxiety
7186521 Determining the effect of a substance on sequestration, uptake, and accumulation of amyloid in brain cells
7189737 Cocaine receptor binding ligands
7196199 Phenoxypropylamine compounds
7223846 Urocortin proteins and uses thereof
7229626 Botulinum toxin therapy for neuropsychiatric disorders
7425617 Antibodies to the cell cycle regulatory protein p16
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional